Compare IFN & ANGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | IFN | ANGO |
|---|---|---|
| Founded | 1993 | 1988 |
| Country | Singapore | United States |
| Employees | N/A | N/A |
| Industry | Finance/Investors Services | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 576.5M | 550.8M |
| IPO Year | N/A | 2004 |
| Metric | IFN | ANGO |
|---|---|---|
| Price | $13.78 | $13.11 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $19.33 |
| AVG Volume (30 Days) | 135.2K | ★ 417.7K |
| Earning Date | 01-01-0001 | 01-06-2026 |
| Dividend Yield | ★ 8.68% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $300,718,000.00 |
| Revenue This Year | N/A | $8.18 |
| Revenue Next Year | N/A | $5.15 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 2.73 |
| 52 Week Low | $14.40 | $8.27 |
| 52 Week High | $21.25 | $13.99 |
| Indicator | IFN | ANGO |
|---|---|---|
| Relative Strength Index (RSI) | 38.19 | 52.98 |
| Support Level | $13.46 | $13.12 |
| Resistance Level | $13.98 | $13.91 |
| Average True Range (ATR) | 0.16 | 0.37 |
| MACD | 0.05 | -0.07 |
| Stochastic Oscillator | 61.54 | 24.27 |
India Fund Inc is an asset management company. The fund's investment objective is long-term capital appreciation, which it seeks to achieve by investing in the equity securities of Indian companies. The company's portfolio is a non-diversified closed-end management investment company across various sectors such as financials, consumer staples, information technology, materials, healthcare, consumer discretionary, industrials, telecommunication services, utilities, and others. Geographically, all the business activity functions through the market of the United States.
AngioDynamics Inc designs manufactures, and sells medical, surgical, and diagnostic devices used by professional healthcare providers for the treatment of peripheral vascular disease and for use in oncology and surgical settings. Geographically, the company derives a majority of its revenue from the United States from sale of Med Tech and Med Device.